Clinical Trial: Ofatumumab versus teriflunomide (UC Davis)
A randomized, double-blind, double-dummy, parallel-group study comparing the efficacy and safety of ofatumumab versus teriflunomide in patients with relapsing multiple sclerosis (COMB157G2301)
More Info
Also Found In: Health & Wellness, Telelearning - Archived